Latest Tax Credits News

ALS Limited has announced an ordinary dividend of AUD 0.194 per share for the half-year ending September 2025, accompanied by a fully franked 30% component and a Dividend Reinvestment Plan with no discount.

Bank of Queensland has updated its dividend details, confirming a fully franked 20-cent payout for the half-year ending August 2025, alongside a refined Dividend Reinvestment Plan price and currency options for shareholders.

Elders Limited has announced a fully franked ordinary dividend of AUD 0.18 per share for the half-year ending September 2025, accompanied by a Dividend Reinvestment Plan offering a modest discount.

Citigroup Global Markets Australia announces a partially franked $2.80 dividend for MQG CitiFirst Self-Funding Instalments, effective with an 18 November record date and ex-dividend trading from 17 November 2025. The dividend triggers adjustments to outstanding loan amounts across multiple instalment securities.

Macquarie Group Limited has announced a quarterly distribution of AUD 1.5799 per security on its perpetual capital notes, reflecting a steady income stream with partial franking. The payment is scheduled for December 12, 2025.

Macquarie Group Limited announces a quarterly dividend of AUD 1.4003 per security on its CAP NOTE 3-BBSW+2.90% PERP NON-CUM RED T-09-27, with a partly franked distribution and a payment date set for December 18, 2025.

Macquarie Group Limited has announced a quarterly distribution of AUD 1.6773 per security for its capital note, payable on December 10, 2025, reflecting a stable income stream for investors.

Macquarie Group Limited has announced an ordinary dividend of AUD 2.80 per share for the half-year ending September 2025, accompanied by a fully franked component and a Dividend Reinvestment Plan available to shareholders.

TPG Telecom has announced a substantial special dividend and capital reduction totaling approximately AUD 3 billion, pending shareholder approval at the upcoming EGM.

Immutep Limited has received a significant A$4.6 million cash payment from the French government’s R&D tax incentive scheme, supporting its ongoing immunotherapy clinical programs.

Mandrake Resources has signed a non-binding Letter of Intent to supply lithium chloride to US refinery Stardust Power, marking a strategic step in the US push for domestic critical minerals.

Invion Limited has secured a pivotal FDA Orphan Drug Designation for its lead cancer drug INV043, bolstered its balance sheet with nearly $1.8 million in new funding, and progressed clinical trials targeting skin and anogenital cancers.